Published in J Med Chem on August 01, 1991
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Protein Sci (1992) 1.13
Protein crystallography and infectious diseases. Protein Sci (1994) 0.95
Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys. Antimicrob Agents Chemother (1994) 0.88
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85
Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
The irregular xylem3 locus of Arabidopsis encodes a cellulose synthase required for secondary cell wall synthesis. Plant Cell (1999) 4.69
Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem (1993) 3.52
Multiple cellulose synthase catalytic subunits are required for cellulose synthesis in Arabidopsis. Plant Cell (2000) 3.41
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Cloning and characterization of irregular xylem4 (irx4): a severely lignin-deficient mutant of Arabidopsis. Plant J (2001) 2.93
Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med (1975) 2.91
Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature (1975) 2.84
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. Science (1990) 2.80
An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc Natl Acad Sci U S A (1990) 2.32
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 2.15
Permeability barrier to rifampin in mycobacteria. Antimicrob Agents Chemother (1977) 2.09
Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2001) 1.95
Cation binding to the integrin CD11b I domain and activation model assessment. Structure (1998) 1.90
Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants. J Biol Chem (1977) 1.81
Nucleotide sequence and expression of the capsid protein gene of feline calicivirus. J Virol (1991) 1.78
Genome-wide association study of body mass index in 23 000 individuals with and without asthma. Clin Exp Allergy (2013) 1.74
Patient management by telephone by child health associates and pediatric house officers. J Med Educ (1974) 1.68
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13. J Biol Chem (1992) 1.63
Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1. J Clin Microbiol (1992) 1.62
A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. J Biol Chem (1991) 1.59
The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry (1994) 1.59
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56
The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem (1992) 1.55
The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Structure (1999) 1.54
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother (1997) 1.53
Evolution of phosphofructokinase--gene duplication and creation of new effector sites. Nature (1984) 1.52
Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry (1991) 1.48
New aspects of chemotaxis. Specific target-cell attraction by lipid and lipoprotein fractions of Escherichia coli chemotactic factor. Am J Pathol (1975) 1.45
The selective S-methylation of sulfhydryl groups in proteins and peptides with methyl-p-nitrobenzenesulfonate. J Biol Chem (1971) 1.41
Autotransplantation of teeth: is there a role? Br J Orthod (1998) 1.41
The covalent and tertiary structure of bovine liver rhodanese. Nature (1978) 1.41
A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem (1984) 1.38
Escherichia coli expression, purification, and biological activity of a truncated soluble CD4. AIDS Res Hum Retroviruses (1990) 1.38
Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1982) 1.37
Sequence of the bacteriophage SP01 gene coding for transcription factor 1, a viral homologue of the bacterial type II DNA-binding proteins. Proc Natl Acad Sci U S A (1984) 1.36
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet (2000) 1.34
Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J Biol Chem (1990) 1.32
Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene. Proc Natl Acad Sci U S A (1987) 1.31
Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J Biol Chem (1991) 1.29
The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol (2001) 1.29
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors. Virology (1992) 1.29
Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2. J Biol Chem (1990) 1.29
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem (1998) 1.29
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease. Biochemistry (1990) 1.26
The location of v-src in a retrovirus vector determines whether the virus is toxic or transforming. Mol Cell Biol (1984) 1.24
Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1996) 1.24
Active site cysteinyl and arginyl residues of rhodanese. A novel formation of disulfide bonds in the active site promoted by phenylglyoxal. J Biol Chem (1978) 1.24
Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene (1990) 1.24
Applications of thermolysin in protein structural analysis. Methods Enzymol (1977) 1.22
The covalent protein structure of insecticyanin, a blue biliprotein from the hemolymph of the tobacco hornworm, Manduca sexta L. J Biol Chem (1984) 1.21
Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method. Proteins (1996) 1.20
Functional characterization of RNA-dependent DNA polymerase and RNase H activities of a recombinant HIV reverse transcriptase. Biochemistry (1991) 1.19
Structural relationships in the adenylate kinase family. Eur J Biochem (1986) 1.18
Purification and properties of methionyl-transfer-ribonucleic acid synthetase from Escherichia coli. Biochem J (1967) 1.18
Purification, physical characterization, and NH2-terminal sequence of glutamine synthetase from the cyanobacterium Anabaena 7120. J Biol Chem (1981) 1.18
Structure of the complex of yeast adenylate kinase with the inhibitor P1,P5-di(adenosine-5'-)pentaphosphate at 2.6 A resolution. J Mol Biol (1987) 1.18
Unwrapping noisy phase maps by use of a minimum-cost-matching algorithm. Appl Opt (1995) 1.17
Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. J Biol Chem (1991) 1.16
Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem (1999) 1.16
The pleiotropic effect of spontaneous single-step variant production in Mycobacterium intracellulare. Scand J Respir Dis (1978) 1.16
Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies. J Protein Chem (1993) 1.14
Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol (1993) 1.13
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Protein Sci (1992) 1.13
Detection and kinetic behavior of preproinsulin in pancreatic islets. Proc Natl Acad Sci U S A (1978) 1.12
Anthranilate synthetase component II from Pseudomonas putida. Covalent structure and identification of the cysteine residue involved in catalysis. J Biol Chem (1978) 1.12
Silkmoth chorion proteins. Their diversity, amino acid composition, and the NH-terminal sequence of one component. J Biol Chem (1978) 1.12
The complete amino acid sequence of adenylate kinase from baker's yeast. Eur J Biochem (1986) 1.11
Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry (1986) 1.11